Targeted anti-cancer therapy in which a therapeutic agent is used specifically to target cancer cells has developed significantly over the last few years. Many of the recent developments are now beginning to move from the scientific realm into clinical practice. This book is a specialist reference text summarising the burgeoning literature on these new types of targeted therapy for molecular oncologists, cancer researchers and those involved with clinical trials as
well as providing a reference for oncologists who are beginning to use some of these therapies in everyday clinical practice.